speb/financial-data huggingface dataset:
Financial ratios for ACQ.TO — quarterly report dated 2025-12-31
Total revenue: 815010218.9781021
Gross profit: 126985401.459854
Operating income: 17341605.839416057
Net income: -9927737.226277372
Capital expenditures: 7335036.496350365
Operating cash flow: 6797810.218978101
Depreciation & amortization: 9581021.897810219
Net tangible assets: -174593430.6569343
Owner earnings: -7681751.824817518
Capex to operating income (%): 42.29733142520414
Buffett classification: The Good
Stock price: 17.262773722627735
P/E ratio: 28.997569264206252
Shares outstanding: 23031304
Book value: 351807299.27007294
P/B ratio: 1.1301192167244842
Market cap (USD): 397584189.48905104
Debt to equity: 3.9144397231397416
Current ratio: 1.0674084313121335
Quick ratio: 0.37205995689424337
Effective tax rate (%): 365.4897494305239
Interest coverage ratio: 1.5627178846280338
COGS to revenue (%): 84.41916450825927
SG&A to revenue (%): 12.291727119985957
Free cash flow (dilution-adjusted): -2505109.4890510947
Buyback yield (%): 0.7628187426733647
Retained earnings: 64013868.61313868
Inventory turnover: 1.0520867748301201
Receivables turnover: 7.669340879742836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6290042010727923
FCF margin (%): -0.3073715434135437
Revenue growth (%): -5.7091344609451795
Rule of 40 score: -6.016506004358723
Financial ratios for ADVENZYMES.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.5162864301727548
Shares outstanding: 111976150
Market cap (USD): 393740216.74798894
Buyback yield (%): 0
Retained earnings: 119648819.72833972
Capitalized R&D asset: 85322.431755242
Rule of 40 score: 0
Financial ratios for ADVENZYMES.NS — annual report dated 2023-03-31
Total revenue: 65819975.63946407
Gross profit: 48430450.669914745
Operating income: 16844823.386114497
Net income: 12867113.276492083
Capital expenditures: 4610353.227771011
Operating cash flow: 17096467.72228989
Depreciation & amortization: 4266626.065773447
Net tangible assets: 103938855.05481121
Owner earnings: 12523386.114494521
Return on net tangible assets (%): 12.048801295617917
Capex to operating income (%): 27.36955515705443
Buffett classification: The Good
Stock price: 2.6808769792935445
P/E ratio: 23.330352062211873
Shares outstanding: 111976150
Book value: 156415468.9403167
P/B ratio: 1.919210962948081
Market cap (USD): 300194282.76492083
Debt to equity: 0.02608608978087809
Current ratio: 9.296031766495629
Quick ratio: 7.697522110202924
Effective tax rate (%): 26.015044020856486
Interest coverage ratio: 57.12350268484098
COGS to revenue (%): 26.419828935826878
R&D to revenue (%): 0.14970890962319247
SG&A to revenue (%): 7.01503751050183
Free cash flow (dilution-adjusted): 12445919.610231426
Buyback yield (%): 0
Retained earnings: 122080024.36053593
Inventory turnover: 1.1514476973949512
Receivables turnover: 5.385455596416221
Capitalized R&D asset: 155704.3971201047
ROCI (R&D-adjusted, %): 10.300685437562377
FCF margin (%): 18.909031018797812
Rule of 40 score: 18.909031018797812
Financial ratios for ADVENZYMES.NS — annual report dated 2024-03-31
Total revenue: 74766398.84878282
Gross profit: 55650077.94699604
Operating income: 20725266.818563376
Net income: 16422952.392373186
Capital expenditures: 5055522.244873486
Operating cash flow: 16952752.128552586
Depreciation & amortization: 4226166.206979254
Net tangible assets: 112788943.51840748
Owner earnings: 15593596.354478955
Return on net tangible assets (%): 13.825465394073873
Capex to operating income (%): 24.393038165112138
Buffett classification: The Great
Stock price: 4.035628598848369
P/E ratio: 27.516011891917458
Shares outstanding: 111976150
Book value: 164417795.89878884
P/B ratio: 2.7484503782492538
Market cap (USD): 451894153.3289348
Debt to equity: 0.03450418648073052
Current ratio: 7.610885978355914
Quick ratio: 6.215068119634814
Effective tax rate (%): 27.084298347895068
Interest coverage ratio: 59.025956284153
COGS to revenue (%): 25.5680642589863
R&D to revenue (%): 0.1302373624047078
SG&A to revenue (%): 6.37104496236429
Free cash flow (dilution-adjusted): 10915577.407362994
Buyback yield (%): 0
Retained earnings: 129450893.3924931
Inventory turnover: 1.073800141457007
Receivables turnover: 6.325348997646294
Capitalized R&D asset: 191550.89476041042
ROCI (R&D-adjusted, %): 12.082047788161505
Rosenberg metric: 73.2671692766841
FCF margin (%): 14.599576247399664
Revenue growth (%): 13.592261501772251
Rule of 40 score: 28.191837749171917
Financial ratios for ADVENZYMES.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 114373626.37362638
Buffett classification: The Gruesome
Stock price: 5.8780458671763025
Shares outstanding: 111976150
Book value: 165884495.9388438
P/B ratio: 3.9678267821513047
Market cap (USD): 658200945.7298137
Debt to equity: 0.03378348700482796
Current ratio: 7.747739341234417
Quick ratio: 6.12766469139603
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADVENZYMES.NS — annual report dated 2025-03-31
Total revenue: 74410451.25087678
Gross profit: 55139700.724807106
Operating income: 18772387.187280804
Net income: 15662146.364274023
Capital expenditures: 3890694.4119710075
Operating cash flow: 16658522.328735093
Depreciation & amortization: 4273556.2310030395
Net tangible assets: 121009469.2541501
Owner earnings: 16045008.183306057
Return on net tangible assets (%): 13.259299691338647
Capex to operating income (%): 20.725624147615815
Buffett classification: The Great
Stock price: 3.191270860077022
P/E ratio: 22.815916554945147
Shares outstanding: 111976150
Book value: 171693944.35351878
P/B ratio: 2.0812977759007953
Market cap (USD): 357346224.51861364
Debt to equity: 0.026792948722313387
Current ratio: 9.141781042526
Quick ratio: 7.5073924382058665
Effective tax rate (%): 28.495335283192073
Interest coverage ratio: 45.14450379533315
COGS to revenue (%): 25.897908428344067
R&D to revenue (%): 0.13746903019134116
SG&A to revenue (%): 6.694191894197549
Free cash flow (dilution-adjusted): 12189618.89174655
Buyback yield (%): 0
Retained earnings: 134799976.61912555
Inventory turnover: 1.047913289469502
Receivables turnover: 5.515706375271884
Capitalized R&D asset: 200049.42358730937
ROCI (R&D-adjusted, %): 10.518898478350385
Rosenberg metric: -5.24142322146986
FCF margin (%): 16.381595174915592
Revenue growth (%): -0.47607963388199603
Rule of 40 score: 15.905515541033596
Financial ratios for ADVENZYMES.NS — quarterly report dated 2025-03-31
Total revenue: 19543956.04395604
Gross profit: 14156184.241290623
Operating income: 4153144.7276128125
Net income: 3124620.0607902734
Capital expenditures: 0
Depreciation & amortization: 1177928.454524199
Net tangible assets: 121009469.2541501
Owner earnings: 4302548.515314473
Return on net tangible assets (%): 3.5555469682112624
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.191270860077022
P/E ratio: 28.591174092077793
Shares outstanding: 111976150
Book value: 171693944.35351878
P/B ratio: 2.0812977759007953
Market cap (USD): 357346224.51861364
Debt to equity: 0.026792948722313387
Current ratio: 9.141781042526
Quick ratio: 7.5073924382058665
Effective tax rate (%): 38.49976990335941
Interest coverage ratio: 43.8051787916153
COGS to revenue (%): 27.567457635229303
Buyback yield (%): 0
Retained earnings: 134799976.61912555
Inventory turnover: 0.29297860843584117
Receivables turnover: 1.4487040615603255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.329421021572356
Rule of 40 score: 0
Financial ratios for ADVENZYMES.NS — quarterly report dated 2025-06-30
Total revenue: 21754505.03159373
Gross profit: 15898080.973554881
Operating income: 5477884.390358062
Net income: 4732038.380528903
Capital expenditures: 0
Depreciation & amortization: 1125438.8017786099
Owner earnings: 5857477.1823075125
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.732623449567049
P/E ratio: 22.08164693898368
Shares outstanding: 111976150
Market cap (USD): 417964803.28223735
Effective tax rate (%): 26.33879781420765
Interest coverage ratio: 61.27486910994764
COGS to revenue (%): 26.920511634411614
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.31065267782005
Rule of 40 score: 11.31065267782005
Financial ratios for ADVENZYMES.NS — quarterly report dated 2025-09-30
Total revenue: 20803607.666290868
Gross profit: 15779143.179255918
Operating income: 5634611.048478016
Net income: 5043179.255918827
Capital expenditures: 0
Depreciation & amortization: 1135963.9233370912
Net tangible assets: 122437880.49605411
Owner earnings: 6179143.179255918
Return on net tangible assets (%): 5.046757714378319
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6561443066516346
P/E ratio: 31.73690808458208
Shares outstanding: 111976150
Book value: 172894024.80270573
P/B ratio: 2.3679300876386473
Market cap (USD): 409400963.30326945
Debt to equity: 0.02259694699296413
Current ratio: 8.745912621450188
Quick ratio: 7.121051990518219
Effective tax rate (%): 24.870257469642766
Interest coverage ratio: 69.2229916897507
COGS to revenue (%): 24.151890228041275
Buyback yield (%): 0
Inventory turnover: 0.2569843677020926
Receivables turnover: 1.4729599208154731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1529209892976438
Revenue growth (%): -4.37103654586435
Rule of 40 score: -4.37103654586435
Financial ratios for ADVENZYMES.NS — quarterly report dated 2025-12-31
Total revenue: 19154394.563885488
Gross profit: 14541940.514648547
Operating income: 4360476.773977944
Net income: 4810404.366714939
Capital expenditures: 0
Depreciation & amortization: 1136905.424974936
Owner earnings: 5947309.791689875
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.3524562771527235
P/E ratio: 21.196500059305592
Shares outstanding: 111976150
Market cap (USD): 375395146.95889497
Effective tax rate (%): 25.91823780686555
Interest coverage ratio: 68.91549295774648
COGS to revenue (%): 24.080395931351735
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.927534151096703
Rule of 40 score: -7.927534151096703
Financial ratios for AISP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.79
Shares outstanding: 34439562
Market cap (USD): 337163311.97999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AISP — annual report dated 2022-12-31
Total revenue: 14549141
Gross profit: 8421013
Operating income: -2823813
Net income: -487493
Capital expenditures: 0
Operating cash flow: -2902659
Depreciation & amortization: 532111
Net tangible assets: -8358411
Owner earnings: 44618
Buffett classification: The Gruesome
Stock price: 10.08
Shares outstanding: 34439562
Book value: -8358411
Market cap (USD): 347150784.96
Debt to equity: -0.15034915129203386
Current ratio: 0.329868473603875
Quick ratio: 0.329868473603875
Interest coverage ratio: -37.522762304666735
COGS to revenue (%): 42.12020489732006
R&D to revenue (%): 24.845549300814394
SG&A to revenue (%): 52.44304113899233
Free cash flow (dilution-adjusted): -3449119
Buyback yield (%): 0
Retained earnings: -10314313
Receivables turnover: 8.694541238761419
Capitalized R&D asset: 3614814
ROCI (R&D-adjusted, %): -27.64720537051892
FCF margin (%): -23.706684813900697
Rule of 40 score: -23.706684813900697
Financial ratios for AISP — annual report dated 2023-12-31
Total revenue: 12299584
Gross profit: 5764317
Operating income: -6640365
Net income: 16371134
Capital expenditures: 0
Operating cash flow: -3291333
Depreciation & amortization: 611435
Net tangible assets: -17487227
Owner earnings: 16982569
Return on net tangible assets (%): -97.11413364737588
Buffett classification: The Gruesome
Stock price: 1.7
P/E ratio: 3.576249232337845
Shares outstanding: 34439562
Book value: -17487227
Market cap (USD): 58547255.4
Debt to equity: -0.2255328417707393
Current ratio: 0.4043609572343007
Quick ratio: 0.4043609572343007
Effective tax rate (%): 0
Interest coverage ratio: -119.24872048127862
COGS to revenue (%): 53.13404908653821
R&D to revenue (%): 22.191742419906234
SG&A to revenue (%): 78.6627417642743
Free cash flow (dilution-adjusted): -6143175
Buyback yield (%): 0
Retained earnings: -17476700
Receivables turnover: 7.426684072665617
Capitalized R&D asset: 5151417.380000001
Rosenberg metric: -0.7349468050085012
FCF margin (%): -49.946201432503734
Revenue growth (%): -15.461785682055043
Rule of 40 score: -65.40798711455878
Financial ratios for AISP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 34439562
Market cap (USD): 79210992.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AISP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.26
Shares outstanding: 34439562
Market cap (USD): 215591658.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AISP — annual report dated 2024-12-31
Total revenue: 23050213
Gross profit: 10526755
Operating income: -3505113
Net income: -57464890
Capital expenditures: 0
Operating cash flow: -6503968
Depreciation & amortization: 224641
Net tangible assets: -53023137
Owner earnings: -57240249
Buffett classification: The Gruesome
Stock price: 6.26
Shares outstanding: 34439562
Book value: -53023137
Market cap (USD): 215591658.12
Debt to equity: -0.0177979473375934
Current ratio: 2.2387162034310735
Quick ratio: 2.2387162034310735
Interest coverage ratio: -3.4942946637211194
COGS to revenue (%): 54.33120292641114
R&D to revenue (%): 12.16862507951662
SG&A to revenue (%): 48.706595466167705
Free cash flow (dilution-adjusted): -7866790
Buyback yield (%): 0
Retained earnings: -74941590
Receivables turnover: 18.789550823838788
Capitalized R&D asset: 5826542.260000001
ROCI (R&D-adjusted, %): -27.01849272274835
Rosenberg metric: 1.7448074586772924
FCF margin (%): -34.128925402988685
Revenue growth (%): 87.40644399030082
Rule of 40 score: 53.27751858731213
Financial ratios for AISP — quarterly report dated 2025-03-31
Total revenue: 5503028
Gross profit: 2235004
Operating income: -1714357
Net income: 23707985
Capital expenditures: 0
Operating cash flow: -2097844
Depreciation & amortization: 83396
Net tangible assets: -23509549
Owner earnings: 23791381
Return on net tangible assets (%): -101.1987979862991
Buffett classification: The Gruesome
Stock price: 3.86
P/E ratio: 1.4018136644678996
Shares outstanding: 34439562
Book value: -23509549
Market cap (USD): 132936709.32
Debt to equity: -0.04952421673422999
Current ratio: 1.8526008461624122
Quick ratio: 1.8526008461624122
Effective tax rate (%): 0
COGS to revenue (%): 59.3859235315539
R&D to revenue (%): 13.072475735177068
SG&A to revenue (%): 58.69457687658504
Free cash flow (dilution-adjusted): -2526130
Buyback yield (%): 0
Retained earnings: -51233605
Receivables turnover: 1.9776213321833505
Capitalized R&D asset: 719382
ROCI (R&D-adjusted, %): -16.787155736047843
FCF margin (%): -45.9043639247338
Rule of 40 score: -45.9043639247338
Financial ratios for AISP — quarterly report dated 2025-06-30
Total revenue: 2146890
Gross profit: 1532517
Operating income: -2021881
Net income: -23757051
Capital expenditures: 0
Operating cash flow: -1820975
Depreciation & amortization: 96608
Net tangible assets: -46879390
Owner earnings: -23660443
Buffett classification: The Gruesome
Stock price: 5.89
Shares outstanding: 34439562
Book value: -46879390
Market cap (USD): 202849020.17999998
Debt to equity: -0.02276759573876708
Current ratio: 1.624312967292487
Quick ratio: 1.624312967292487
COGS to revenue (%): 28.616883026144794
R&D to revenue (%): 34.49506029652195
SG&A to revenue (%): 131.0652618438765
Free cash flow (dilution-adjusted): -2193114
Buyback yield (%): 0
Retained earnings: -74990656
Receivables turnover: 0.8394726418388482
Capitalized R&D asset: 1222556.94
ROCI (R&D-adjusted, %): -30.400816751778052
Rosenberg metric: -0.9765145638895608
FCF margin (%): -102.15306792616296
Revenue growth (%): -60.9871147302903
Rule of 40 score: -163.14018265645325
Financial ratios for AISP — quarterly report dated 2025-09-30
Total revenue: 1177450
Gross profit: 603836
Operating income: -2866781
Net income: 6409873
Capital expenditures: 0
Operating cash flow: -583602
Depreciation & amortization: 98330
Net tangible assets: -40081108
Owner earnings: 6508203
Return on net tangible assets (%): -16.23758255385555
Buffett classification: The Gruesome
Stock price: 5.17
P/E ratio: 27.992129857107756
Shares outstanding: 34439562
Book value: -40081108
Market cap (USD): 178052535.54
Debt to equity: -0.024122910973419197
Current ratio: 1.2871117071983635
Quick ratio: 1.2871117071983635
Effective tax rate (%): 0
COGS to revenue (%): 48.71663340269226
R&D to revenue (%): 63.9712089685337
SG&A to revenue (%): 230.78585077922628
Free cash flow (dilution-adjusted): -939022
Buyback yield (%): 0
Retained earnings: -68580783
Receivables turnover: 0.9439831446756689
Capitalized R&D asset: 1486807.6300000001
ROCI (R&D-adjusted, %): -69.13017477757299
Rosenberg metric: -1.2540067056365967
FCF margin (%): -79.75047772729202
Revenue growth (%): -45.15555058712836
Rule of 40 score: -124.90602831442038
Financial ratios for AISP — quarterly report dated 2025-12-31
Total revenue: 6493981
Gross profit: 3326409
Operating income: -612767
Net income: 22960556
Capital expenditures: 0
Operating cash flow: -3502403
Depreciation & amortization: 100114
Net tangible assets: -7149642
Owner earnings: 23060670
Return on net tangible assets (%): -322.5430028524505
Buffett classification: The Gruesome
Stock price: 2.89
P/E ratio: 3.3944647859651003
Shares outstanding: 34439562
Book value: -7149642
Market cap (USD): 99530334.18
Debt to equity: -0.12080940556184491
Current ratio: 2.9448384020601743
Quick ratio: 2.9448384020601743
Effective tax rate (%): 0
COGS to revenue (%): 48.777044466252676
R&D to revenue (%): 13.293602183314057
SG&A to revenue (%): 47.365275629848625
Free cash flow (dilution-adjusted): -3976550
Buyback yield (%): 0
Retained earnings: -45620227
Receivables turnover: 1.00484412414364
Capitalized R&D asset: 1612335.86
ROCI (R&D-adjusted, %): -3.615296121981081
Rosenberg metric: 3.6145355529327734
FCF margin (%): -61.23439535779362
Revenue growth (%): 451.52923691027223
Rule of 40 score: 390.2948415524786
Financial ratios for AISP — annual report dated 2025-12-31
Total revenue: 15321349
Gross profit: 7697766
Operating income: -7215786
Net income: 29321363
Capital expenditures: 0
Operating cash flow: -8004824
Depreciation & amortization: 378448
Net tangible assets: -7149642
Owner earnings: 29699811
Return on net tangible assets (%): -415.40277121567766
Buffett classification: The Gruesome
Stock price: 2.89
P/E ratio: 3.3944647859651003
Shares outstanding: 34439562
Book value: -7149642
Market cap (USD): 99530334.18
Debt to equity: -0.12080940556184491
Current ratio: 2.9448384020601743
Quick ratio: 2.9448384020601743
Effective tax rate (%): 0
COGS to revenue (%): 49.757909698421464
R&D to revenue (%): 20.079602651176472
SG&A to revenue (%): 77.25877140452842
Free cash flow (dilution-adjusted): -9634816
Buyback yield (%): 0
Retained earnings: -45620227
Receivables turnover: 2.370744157798435
Capitalized R&D asset: 5856477.340000001
ROCI (R&D-adjusted, %): -36.80105608134496
Rosenberg metric: -1.0085903424514437
FCF margin (%): -62.88490654445636
Revenue growth (%): -33.530553492065344
Rule of 40 score: -96.41546003652171
Financial ratios for ALCOF.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 308.15909090909093
Shares outstanding: 38344
Market cap (USD): 11816052.181818184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALCOF.PA — annual report dated 2022-12-31
Total revenue: 59381914.89361703
Gross profit: 22700000
Operating income: 720212.7659574469
Net income: 765957.4468085107
Capital expenditures: 1194680.8510638298
Operating cash flow: -1223404.255319149
Depreciation & amortization: 370212.7659574468
Net tangible assets: 27769148.936170213
Owner earnings: -58510.638297872385
Return on net tangible assets (%): -0.21070375052675955
Capex to operating income (%): 165.8788774002954
Buffett classification: The Gruesome
Stock price: 286.69148936170217
P/E ratio: 14.351839666666667
Shares outstanding: 38344
Book value: 27808510.638297874
P/B ratio: 0.3953069839326703
Market cap (USD): 10992898.468085108
Debt to equity: 0.14774292272379494
Current ratio: 2.1485010751781424
Quick ratio: 1.01366108698402
Effective tax rate (%): 32.64346190028222
Interest coverage ratio: 14.104166666666666
COGS to revenue (%): 61.77287303606299
SG&A to revenue (%): 13.67813826833157
Free cash flow (dilution-adjusted): -2438297.872340426
Buyback yield (%): 0
Retained earnings: 765957.4468085107
Inventory turnover: 1.281107189299647
Receivables turnover: 8.535015290519878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2166923152483546
FCF margin (%): -4.106128737526649
Rule of 40 score: -4.106128737526649
Financial ratios for ALCOF.PA — annual report dated 2023-12-31
Total revenue: 82118888.88888888
Gross profit: 31244444.444444444
Operating income: 2573333.3333333335
Net income: 2443333.3333333335
Capital expenditures: 2731111.111111111
Operating cash flow: -2844444.4444444445
Depreciation & amortization: 1534444.4444444445
Net tangible assets: 30791111.111111112
Owner earnings: 1246666.666666667
Return on net tangible assets (%): 4.0487875288683615
Capex to operating income (%): 106.13126079447322
Buffett classification: The Gruesome
Stock price: 309.64444444444445
P/E ratio: 4.859347849022282
Shares outstanding: 38344
Book value: 30846666.666666664
P/B ratio: 0.38490403861393274
Market cap (USD): 11873006.577777779
Debt to equity: 0.11292414091203803
Current ratio: 1.9895092069547353
Quick ratio: 0.8449123321839922
Effective tax rate (%): 25.925925925925924
Interest coverage ratio: 51.46666666666667
COGS to revenue (%): 61.952183149092775
R&D to revenue (%): 0
SG&A to revenue (%): 0.6169916246093062
Free cash flow (dilution-adjusted): -5575555.555555555
Buyback yield (%): 0
Retained earnings: 2443333.3333333335
Inventory turnover: 1.4673439302653504
Receivables turnover: 14.314739492543094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.2554117978760075
FCF margin (%): -6.789613974319077
Revenue growth (%): 38.28939170453706
Rule of 40 score: 31.499777730217982
Financial ratios for ALCOF.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 28537500
Buffett classification: The Gruesome
Stock price: 317.11458333333337
Shares outstanding: 38344
Book value: 29869791.66666667
P/B ratio: 0.40708156652136007
Market cap (USD): 12159441.583333334
Debt to equity: 0.42605056669572794
Current ratio: 1.8566332218506132
Quick ratio: 0.8685140946010511
Buyback yield (%): 0
Retained earnings: 1663541.6666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALCOF.PA — annual report dated 2024-12-31
Total revenue: 82813541.66666667
Gross profit: 31163541.666666668
Operating income: 1422916.6666666667
Net income: 1663541.6666666667
Capital expenditures: 3739583.3333333335
Operating cash flow: 7987500
Depreciation & amortization: 1565625
Net tangible assets: 28537500
Owner earnings: -510416.6666666665
Return on net tangible assets (%): -1.7885822747846396
Capex to operating income (%): 262.8111273792093
Buffett classification: The Gruesome
Stock price: 317.11458333333337
P/E ratio: 7.3093700187852235
Shares outstanding: 38344
Book value: 29869791.66666667
P/B ratio: 0.40708156652136007
Market cap (USD): 12159441.583333334
Debt to equity: 0.42605056669572794
Current ratio: 1.8566332218506132
Quick ratio: 0.8685140946010511
Effective tax rate (%): 18.631955079122005
Interest coverage ratio: 5.4639999999999995
COGS to revenue (%): 62.36902680469427
R&D to revenue (%): 0.0012578458132602105
SG&A to revenue (%): 1.0490434082590154
Free cash flow (dilution-adjusted): 4065625
Buyback yield (%): 0.32553578272532924
Retained earnings: 1663541.6666666667
Inventory turnover: 1.5983495583779253
Receivables turnover: 13.397539602291879
Capitalized R&D asset: 1041.6666666666667
ROCI (R&D-adjusted, %): 3.26773944161506
FCF margin (%): 4.9093722091546015
Revenue growth (%): 0.8459110774351711
Rule of 40 score: 5.755283286589773
Financial ratios for ALCOF.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -2923529.411764706
Buffett classification: The Gruesome
Stock price: 337.59999999999997
Shares outstanding: 38344
Book value: 0
Market cap (USD): 12944934.399999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSGD.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2613636363636365
Shares outstanding: 96884822
Market cap (USD): 122206991.38636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSGD.PA — annual report dated 2022-12-31
Total revenue: 5957045.744680852
Gross profit: 5015471.276595745
Operating income: -1623773.4042553192
Net income: -2545924.4680851065
Capital expenditures: 36359.574468085106
Operating cash flow: -1491525.5319148938
Depreciation & amortization: 311103.1914893617
Net tangible assets: 839756.3829787235
Owner earnings: -2271180.85106383
Return on net tangible assets (%): -270.45711078820983
Buffett classification: The Gruesome
Stock price: 0.6063829787234042
Shares outstanding: 96884822
Book value: 5469372.340425532
P/B ratio: 10.741508037991055
Market cap (USD): 58749306.9574468
Debt to equity: 0.7445749152436878
Current ratio: 1.9250402082624465
Quick ratio: 1.675037195870326
Interest coverage ratio: -2.881204696466324
COGS to revenue (%): 15.806064086814414
R&D to revenue (%): 16.09035108256395
SG&A to revenue (%): 51.90229770825643
Free cash flow (dilution-adjusted): -2414141.489361702
Buyback yield (%): 0
Retained earnings: -2545924.4680851065
Inventory turnover: 1.0156860539974821
Receivables turnover: 5.102562023083358
Capitalized R&D asset: 958509.5744680852
ROCI (R&D-adjusted, %): -10.37893941364572
FCF margin (%): -40.52581754164521
Rule of 40 score: -40.52581754164521
Financial ratios for ALSGD.PA — annual report dated 2023-12-31
Total revenue: 4791997.777777778
Gross profit: 3754504.4444444445
Operating income: -3951216.6666666665
Net income: -4648235.555555555
Capital expenditures: 80197.77777777778
Operating cash flow: -4054143.333333333
Depreciation & amortization: 323742.2222222222
Net tangible assets: 1899283.3333333333
Owner earnings: -4404691.111111111
Return on net tangible assets (%): -231.91332403157915
Buffett classification: The Gruesome
Stock price: 0.22222222222222224
Shares outstanding: 96884822
Book value: 6702163.333333333
P/B ratio: 3.212389697721151
Market cap (USD): 21529960.444444448
Debt to equity: 0.5114603957892866
Current ratio: 2.041069603339281
Quick ratio: 1.7339839656383467
Interest coverage ratio: -8.609690727639856
COGS to revenue (%): 21.650538699007
R&D to revenue (%): 33.237772786947126
SG&A to revenue (%): 62.81207698575264
Free cash flow (dilution-adjusted): -4566379.999999999
Buyback yield (%): 0
Retained earnings: -4648235.555555555
Inventory turnover: 0.9819757004805006
Receivables turnover: 5.770262423436418
Capitalized R&D asset: 2234954.7482269504
ROCI (R&D-adjusted, %): -29.024109069979726
Rosenberg metric: -1.3155495424769867
FCF margin (%): -95.29178041726041
Revenue growth (%): -19.557478939008735
Rule of 40 score: -114.84925935626914
Financial ratios for ALSGD.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -622829.1666666667
Buffett classification: The Gruesome
Stock price: 0.22916666666666669
Shares outstanding: 96884822
Book value: 4066340.625
P/B ratio: 5.460135722971642
Market cap (USD): 22202771.708333336
Debt to equity: 0.6436422797217093
Current ratio: 0.9656569441947499
Quick ratio: 0.6928742527099945
Buyback yield (%): 0
Retained earnings: -3210280.2083333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSGD.PA — annual report dated 2024-12-31
Total revenue: 4841705.208333334
Gross profit: 3778917.7083333335
Operating income: -3190062.5
Net income: -3210280.2083333335
Capital expenditures: 64543.75
Operating cash flow: -2444318.75
Depreciation & amortization: 325798.9583333334
Net tangible assets: -622829.1666666667
Owner earnings: -2949025
Buffett classification: The Gruesome
Stock price: 0.22916666666666669
Shares outstanding: 96884822
Book value: 4066340.625
P/B ratio: 5.460135722971642
Market cap (USD): 22202771.708333336
Debt to equity: 0.6436422797217093
Current ratio: 0.9656569441947499
Quick ratio: 0.6928742527099945
Interest coverage ratio: -10.404639595564253
COGS to revenue (%): 21.950685848671167
R&D to revenue (%): 27.735708644315864
SG&A to revenue (%): 61.05342965213056
Free cash flow (dilution-adjusted): -3171180.2083333335
Buyback yield (%): 0
Retained earnings: -3210280.2083333335
Inventory turnover: 1.1838428282012545
Receivables turnover: 7.4273996637882
Capitalized R&D asset: 2726334.1429078015
ROCI (R&D-adjusted, %): -39.278124804208545
Rosenberg metric: 0.015327711691424698
FCF margin (%): -65.49717655001454
Revenue growth (%): 1.0373007847805618
Rule of 40 score: -64.45987576523399
Financial ratios for ALSGD.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -198488.23529411765
Buffett classification: The Gruesome
Stock price: 0.12941176470588237
Shares outstanding: 96884822
Book value: 5039939.999999999
P/B ratio: 2.4877351294331476
Market cap (USD): 12538035.788235296
Debt to equity: 0.5317813073871795
Current ratio: 1.0669155325549688
Quick ratio: 0.8202448210617768
Buyback yield (%): 0
Retained earnings: -1274464.705882353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVAP.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.909090909090908
Shares outstanding: 2737593
Market cap (USD): 29864650.909090906
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVAP.PA — annual report dated 2022-12-31
Total revenue: 59414751.06382979
Gross profit: 6867372.340425532
Operating income: 3320014.8936170214
Net income: 2371946.8085106383
Capital expenditures: 1017021.2765957448
Operating cash flow: -2143617.021276596
Depreciation & amortization: 243617.02127659577
Net tangible assets: 12400195.744680852
Owner earnings: 1598542.553191489
Return on net tangible assets (%): 12.891268703376676
Capex to operating income (%): 30.633033561115784
Buffett classification: The Good
Stock price: 9.446808510638299
P/E ratio: 10.903076223409265
Shares outstanding: 2737593
Book value: 12554079.787234046
P/B ratio: 2.0600089603828877
Market cap (USD): 25861516.851063833
Debt to equity: 0.0664860579781007
Current ratio: 3.2802397505281413
Quick ratio: 1.257121062876035
Effective tax rate (%): 25.638720973860842
Interest coverage ratio: 1148.6249539933751
COGS to revenue (%): 88.44163744278278
Free cash flow (dilution-adjusted): -3160638.297872341
Buyback yield (%): 0
Retained earnings: 2371944.680851064
Inventory turnover: 4.839859930325743
Receivables turnover: 18.214696506879203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.170067664733356
FCF margin (%): -5.319618851010315
Rule of 40 score: -5.319618851010315
Financial ratios for ALVAP.PA — annual report dated 2023-12-31
Total revenue: 66840869.94444445
Gross profit: 8589909.566666666
Operating income: 4050668.411111111
Net income: 2821698.5111111114
Capital expenditures: 3066666.6666666665
Operating cash flow: 6935555.555555555
Depreciation & amortization: 200324.48888888888
Net tangible assets: 16509182.911111109
Owner earnings: -44643.666666666046
Return on net tangible assets (%): -0.2704171787727889
Capex to operating income (%): 75.70766983184068
Buffett classification: The Gruesome
Stock price: 7.944444444444445
P/E ratio: 7.707646800095573
Shares outstanding: 2737593
Book value: 16603501.944444444
P/B ratio: 1.3098836361612938
Market cap (USD): 21748655.5
Debt to equity: 0.23948848608861917
Current ratio: 4.011266152051342
Quick ratio: 2.6294169300011934
Effective tax rate (%): 25.255014092839538
Interest coverage ratio: 53.003587220057845
COGS to revenue (%): 87.14871668515644
Free cash flow (dilution-adjusted): 3868888.888888889
Buyback yield (%): 0
Retained earnings: 2821698.5111111114
Inventory turnover: 7.7639666548009645
Receivables turnover: 14.876689329013164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.491790804274192
FCF margin (%): 5.788208460040332
Revenue growth (%): 12.498779760327054
Rule of 40 score: 18.286988220367384
Financial ratios for ALVAP.PA — annual report dated 2024-12-31
Total revenue: 63212689.583333336
Gross profit: 14874823.958333334
Operating income: 3728513.541666667
Net income: 2752021.875
Capital expenditures: 553851.0416666667
Operating cash flow: -1144825
Depreciation & amortization: 879558.3333333334
Net tangible assets: 13945645.833333334
Owner earnings: 3077729.166666667
Return on net tangible assets (%): 22.069463138882956
Capex to operating income (%): 14.854473115822241
Buffett classification: The Great
Stock price: 5
P/E ratio: 4.973784955833609
Shares outstanding: 2737593
Book value: 17165111.458333336
P/B ratio: 0.7974294273140157
Market cap (USD): 13687965
Debt to equity: 0.2521320044346251
Current ratio: 2.1707082798260537
Quick ratio: 1.1593209879669417
Effective tax rate (%): 27.755663119358175
Interest coverage ratio: 18.363481053571245
COGS to revenue (%): 76.46861088116835
Free cash flow (dilution-adjusted): -1504055.2083333335
Buyback yield (%): 0
Retained earnings: 2752021.875
Inventory turnover: 4.384280860175717
Receivables turnover: 17.49826687400934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.71764218916504
FCF margin (%): -2.379356452394794
Revenue growth (%): -5.428086684279716
Rule of 40 score: -7.80744313667451
Financial ratios for ALVAP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13945645.833333334
Buffett classification: The Gruesome
Stock price: 5
Shares outstanding: 2737593
Book value: 17165111.458333336
P/B ratio: 0.7974294273140157
Market cap (USD): 13687965
Debt to equity: 0.2521320044346251
Current ratio: 2.1707082798260537
Quick ratio: 1.1593209879669417
Buyback yield (%): 0
Retained earnings: 2752021.875
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVAP.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 20511164.70588235
Buffett classification: The Gruesome
Stock price: 5.541176470588235
Shares outstanding: 2737593
Book value: 20654000
P/B ratio: 0.7344575345040698
Market cap (USD): 15169485.917647058
Debt to equity: 0.17884893397661186
Current ratio: 3.6226298998392483
Quick ratio: 1.9784983306541366
Buyback yield (%): 0
Retained earnings: 985485.8823529412
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANG.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09022556390977443
Shares outstanding: 623110874
Market cap (USD): 56220529.984962404
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANG.AX — annual report dated 2022-06-30
Total revenue: 139949655.1724138
Gross profit: 96935862.06896552
Operating income: 17554482.75862069
Net income: 11591034.48275862
Capital expenditures: 6248275.862068966
Depreciation & amortization: 3480689.6551724137
Net tangible assets: 66022068.965517245
Owner earnings: 8823448.275862068
Return on net tangible assets (%): 13.364392261730663
Capex to operating income (%): 35.59361986328279
Buffett classification: The Good
Stock price: 0.14482758620689656
P/E ratio: 7.785641907538526
Shares outstanding: 623110874
Book value: 74013793.10344829
P/B ratio: 1.2192814344017888
Market cap (USD): 90243643.82068966
Debt to equity: 0.33788669399925453
Current ratio: 1.3843029695659055
Quick ratio: 0.9585210190410887
Effective tax rate (%): 21.77263237806035
Interest coverage ratio: 23.99057492931197
COGS to revenue (%): 30.735190487219544
SG&A to revenue (%): 28.204231078170967
Free cash flow (dilution-adjusted): 377931.0344827586
Buyback yield (%): 0
Retained earnings: -23488965.51724138
Inventory turnover: 1.5452653485952135
Receivables turnover: 3.721382725105447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.327367636092468
FCF margin (%): 0.2700478497193572
Rule of 40 score: 0.2700478497193572
Financial ratios for ANG.AX — annual report dated 2023-06-30
Total revenue: 171058278.14569536
Gross profit: 110334437.08609271
Operating income: 7858940.397350993
Net income: 1886754.9668874172
Capital expenditures: 7120529.8013245035
Depreciation & amortization: 5235099.337748344
Net tangible assets: 58334437.08609272
Owner earnings: 1324.5033112578094
Return on net tangible assets (%): 0.002270534143156374
Capex to operating income (%): 90.60419651133395
Buffett classification: The Gruesome
Stock price: 0.16556291390728478
P/E ratio: 54.67803387153387
Shares outstanding: 623110874
Book value: 75627814.56953642
P/B ratio: 1.3641019851486018
Market cap (USD): 103164051.98675497
Debt to equity: 0.4855076271038022
Current ratio: 1.2159275452841973
Quick ratio: 0.679153653966271
Effective tax rate (%): 23.960671155284814
Interest coverage ratio: 3.901051939513478
COGS to revenue (%): 35.49891985226367
SG&A to revenue (%): 28.15662529326592
Free cash flow (dilution-adjusted): 3152317.880794702
Buyback yield (%): 0
Retained earnings: -21825165.562913906
Inventory turnover: 1.3337163636363636
Receivables turnover: 5.457384322839636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.937003426591858
FCF margin (%): 1.842832697117283
Revenue growth (%): 22.228438458784815
Rule of 40 score: 24.0712711559021
Financial ratios for ANG.AX — annual report dated 2024-06-30
Total revenue: 208826666.66666666
Gross profit: 126999333.33333333
Operating income: 22988000
Net income: 17388000
Capital expenditures: 2930000
Depreciation & amortization: 6086000
Net tangible assets: 69596000
Owner earnings: 20544000
Return on net tangible assets (%): 29.518937869992527
Capex to operating income (%): 12.745780407168958
Buffett classification: The Great
Stock price: 0.36000000000000004
P/E ratio: 12.900846252587993
Shares outstanding: 623110874
Book value: 86896000.00000001
P/B ratio: 2.5814757254649234
Market cap (USD): 224319914.64000002
Debt to equity: 0.35305038973792424
Current ratio: 1.2303015418926186
Quick ratio: 0.7631472397931753
Effective tax rate (%): 18.441001977587344
Interest coverage ratio: 15.64519056261343
COGS to revenue (%): 39.18433150300089
SG&A to revenue (%): 26.292938322053377
Free cash flow (dilution-adjusted): 20006666.666666668
Buyback yield (%): 0
Retained earnings: -6146000
Inventory turnover: 1.7439507821713247
Receivables turnover: 6.504828159069671
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.224924652770454
FCF margin (%): 9.580513344400462
Revenue growth (%): 22.079252129968744
Rule of 40 score: 31.659765474369205
Financial ratios for APL.V — annual report dated 2021-12-31
Gross profit: 2221455.905511811
Capital expenditures: 183354.3307086614
Depreciation & amortization: 400470.0787401575
Buffett classification: The Gruesome
Stock price: 0.10236220472440945
Shares outstanding: 14772304
Market cap (USD): 1512125.6062992127
Buyback yield (%): 0
Inventory turnover: 0.9327013507881355
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APL.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 2028627.9411764704
Operating income: -141397.0588235294
Net income: 174663.23529411762
Capital expenditures: 149162.5
Operating cash flow: 87194.11764705881
Depreciation & amortization: 375495.5882352941
Net tangible assets: 4858139.705882353
Owner earnings: 400996.3235294117
Return on net tangible assets (%): 8.254112639944786
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
P/E ratio: 6.218817724865499
Shares outstanding: 14772304
Book value: 4858139.705882352
P/B ratio: 0.2235832827561991
Market cap (USD): 1086198.8235294118
Debt to equity: 0.2719511069203142
Current ratio: 2.572248224631163
Quick ratio: 0.6013879650961731
Interest coverage ratio: -1.7268939257875642
Free cash flow (dilution-adjusted): 57782.35294117646
Buyback yield (%): 0
Retained earnings: 2833908.088235294
Inventory turnover: 1.1128371786756222
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.7958554459861955
Rule of 40 score: 0
Financial ratios for APL.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -131212.12121212122
Net income: 1279103.7878787878
Capital expenditures: 0
Operating cash flow: 211946.9696969697
Net tangible assets: 6334421.96969697
Owner earnings: 1279103.7878787878
Return on net tangible assets (%): 20.192904640673607
Buffett classification: The Gruesome
Stock price: 0.11363636363636363
P/E ratio: 1.3123805315866874
Shares outstanding: 14772304
Book value: 6334421.96969697
P/B ratio: 0.26500774926606513
Market cap (USD): 1678670.909090909
Debt to equity: 0
Current ratio: 14.919213563195944
Quick ratio: 14.919213563195944
Free cash flow (dilution-adjusted): 211946.9696969697
Buyback yield (%): 0
Retained earnings: 4198887.878787879
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.050265356659166
Rule of 40 score: 0
Financial ratios for APL.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14074074074074072
Shares outstanding: 14772304
Market cap (USD): 2079065.007407407
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APL.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -390572.7272727273
Net income: -101079.72027972028
Capital expenditures: 0
Operating cash flow: -406809.7902097902
Net tangible assets: 2858528.6713286713
Owner earnings: -101079.72027972028
Return on net tangible assets (%): -3.5360750897327002
Buffett classification: The Gruesome
Stock price: 0.15384615384615385
Shares outstanding: 14772304
Book value: 2858528.6713286713
P/B ratio: 0.7950461286749309
Market cap (USD): 2272662.153846154
Debt to equity: 0
Current ratio: 135.82640682732236
Quick ratio: 135.82640682732236
Free cash flow (dilution-adjusted): -446669.9300699301
Buyback yield (%): 61.36501978789004
Retained earnings: 2225242.6573426574
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.54512154544458
Rule of 40 score: 0
Financial ratios for APL.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -75425.87412587414
Net income: -17072.027972027972
Capital expenditures: 0
Operating cash flow: -11447.552447552449
Net tangible assets: 2858528.6713286713
Owner earnings: -17072.027972027972
Return on net tangible assets (%): -0.5972313009578012
Buffett classification: The Gruesome
Stock price: 0.15384615384615385
Shares outstanding: 14772304
Book value: 2858528.6713286713
P/B ratio: 0.7950461286749309
Market cap (USD): 2272662.153846154
Debt to equity: 0
Current ratio: 135.82640682732236
Quick ratio: 135.82640682732236
Free cash flow (dilution-adjusted): -11447.552447552449
Buyback yield (%): 0
Retained earnings: 2225242.6573426574
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6157807787561516
Rule of 40 score: 0
Financial ratios for APL.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -44560.13986013986
Net income: -16213.986013986014
Capital expenditures: 0
Operating cash flow: -78479.72027972028
Net tangible assets: 2842314.6853146856
Owner earnings: -16213.986013986014
Return on net tangible assets (%): -0.5704500665516876
Buffett classification: The Gruesome
Stock price: 0.14685314685314685
Shares outstanding: 14772304
Book value: 2842314.6853146856
P/B ratio: 0.7632368575793883
Market cap (USD): 2169359.3286713287
Debt to equity: 0
Free cash flow (dilution-adjusted): -78479.72027972028
Buyback yield (%): 0
Retained earnings: 2209028.6713286713
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5540911319176334
Rule of 40 score: 0
Financial ratios for APL.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -59995.6204379562
Net income: -14551.824817518247
Capital expenditures: 0
Operating cash flow: -18695.620437956204
Net tangible assets: 2952243.7956204377
Owner earnings: -14551.824817518247
Return on net tangible assets (%): -0.4929072876401816
Buffett classification: The Gruesome
Stock price: 0.1897810218978102
Shares outstanding: 14772304
Book value: 2952243.7956204377
P/B ratio: 0.9496176952133897
Market cap (USD): 2803502.9489051094
Debt to equity: 0
Current ratio: 516.5766995198384
Quick ratio: 516.5766995198384
Free cash flow (dilution-adjusted): -18695.620437956204
Buyback yield (%): 0
Retained earnings: 2291222.627737226
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.014423541164147
Rule of 40 score: 0
Financial ratios for APL.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -36624.460431654676
Net income: -19207.194244604318
Capital expenditures: 0
Operating cash flow: 8120.143884892087
Net tangible assets: 2890558.273381295
Owner earnings: -19207.194244604318
Return on net tangible assets (%): -0.6644804369273716
Buffett classification: The Gruesome
Stock price: 0.18705035971223025
Shares outstanding: 14772304
Book value: 2890558.273381295
P/B ratio: 0.9559277190236832
Market cap (USD): 2763164.7769784178
Debt to equity: 0
Current ratio: 142.99656706484046
Quick ratio: 142.99656706484046
Free cash flow (dilution-adjusted): 8120.143884892087
Buyback yield (%): 0
Retained earnings: 2239048.201438849
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2558787598900327
Rule of 40 score: 0
Financial ratios for ASP.AX — annual report dated 2021-09-30
Capital expenditures: 0
Net tangible assets: -1430935.2517985613
Buffett classification: The Gruesome
Stock price: 4.496402877697842
Shares outstanding: 11756686
Book value: 4694244.6043165475
P/B ratio: 11.261193486590036
Market cap (USD): 52862796.76258993
Debt to equity: 0.0853639846743295
Current ratio: 0.7502452073116362
Quick ratio: 0.7502452073116362
Buyback yield (%): 0.93904013426913
Retained earnings: -2724460.4316546763
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASP.AX — annual report dated 2022-09-30
Total revenue: 12161688.311688311
Gross profit: 7812337.662337662
Operating income: -531168.8311688312
Net income: -278571.4285714286
Capital expenditures: 22077.922077922078
Depreciation & amortization: 653896.1038961039
Net tangible assets: -827272.7272727273
Owner earnings: 353246.75324675324
Buffett classification: The Gruesome
Stock price: 4.058441558441558
Shares outstanding: 11756686
Book value: 4448051.948051948
P/B ratio: 10.726903284671533
Market cap (USD): 47713823.05194805
Debt to equity: 0.0051094890510948905
Current ratio: 0.8082768535633601
Quick ratio: 0.8082768535633601
COGS to revenue (%): 35.76272091409045
SG&A to revenue (%): 56.51663196112979
Free cash flow (dilution-adjusted): 492207.79220779217
Buyback yield (%): 0.004082783192474479
Retained earnings: -2737012.987012987
Receivables turnover: 15.140662894098625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.942871034398932
FCF margin (%): 4.047199530140424
Rule of 40 score: 4.047199530140424
Financial ratios for ASP.AX — annual report dated 2023-09-30
Total revenue: 12338461.538461538
Gross profit: 7092948.717948718
Operating income: -1394871.7948717948
Net income: -590384.6153846154
Capital expenditures: 12820.51282051282
Depreciation & amortization: 471153.8461538461
Net tangible assets: -2422435.8974358975
Owner earnings: -132051.28205128206
Buffett classification: The Gruesome
Stock price: 1.6025641025641024
Shares outstanding: 11756686
Book value: 1842307.692307692
P/B ratio: 10.226762352122478
Market cap (USD): 18840842.948717948
Debt to equity: 0.17258176757132918
Current ratio: 0.5812995491994404
Quick ratio: 0.5812995491994404
Interest coverage ratio: -31.536231884057973
COGS to revenue (%): 42.51350789692435
SG&A to revenue (%): 56.385078969243565
Free cash flow (dilution-adjusted): -1052564.1025641025
Buyback yield (%): 0.010206957981186196
Retained earnings: -3762820.5128205125
Receivables turnover: 5.603493449781659
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.46945898778358
FCF margin (%): -8.530756442227764
Revenue growth (%): 1.453525384327882
Rule of 40 score: -7.077231057899882